Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis.
Vanita R ArodaNick NielsenKamal K ManglaJasjit MultaniVictoria DivinoTarlan NamvarJigar RajpuraPublished in: BMJ open diabetes research & care (2024)
Persistence and adherence to basal insulin was associated with fewer hospitalizations and lower direct medical costs.